-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

908. Outcomes Research: Myeloid Malignancies: Poster II

Symposia: Outcomes Research: Myeloid Malignancies Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 8, 2024: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Lisa Pleyer, MD1,2,3,4*, Patrick Klammer, MSc5*, Manuel Drost, MSc5*, Hubert Angermann6*, Felix Keil, MD7*, Verena Petzer, MD8*, Sonja Heibl, MD9*, Jennifer Moritz, MD10*, Michael Girschikofsky11*, Margarete Stampfl-Mattersberger, MD12*, Angelika Pichler, MD13*, Bernd L. Hartmann, MD14*, Gregor Aschauer, MD15*, Clemens Schmitt16,17, Sonia Vallet, MD18*, Szilvia Boros, MD19*, Petra Pichler19*, Andrea Hammerl-Steiner, MD20*, Felix Renneberg, MD21*, Susanne Schnabel, MD21*, Dilyan Majjiga, MD21*, Thomas Melchardt, MD1*, Alexander Egle, MD21, Michael Leisch, MD21* and Richard Greil, MD1,2,3,4

13rd Medical Dept. with Haematology, Medical Oncology, Haemostaseology, Rheumatology and Infectiology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria
2Austrian Group of Medical Tumor Therapy (AGMT) Study Group, Vienna, Austria
3Salzburg Cancer Research Institute (SCRI), Center for Clinical Cancer and Immunology Trials (CCCIT), and Cancer Cluster Salzburg (CCS), Salzburg, Austria
4Laboratory for Molecular Cytology, Salzburg, Austria
5Assign Data Management and Biostatistics GmbH, Innsbruck, Austria
6Unidata Geodesign GmbH, Vienna, Austria
7Department of Haematology, Hanusch Krankenhaus, Wien, AUT
8Department of Hematology and Oncology, Comprehensive Cancer Center Innsbruck (CCCI), Medical University of Innsbruck (MUI), Innsbruck, Tirol, AUT
94th Medical Dept. of Internal Medicine, Hematology, Internistic Oncology and Palliative Medicine, Klinikum Wels-Grieskirchen GmbH, Wels, AUT
10Division of Hematology, Medical University of Graz, Graz, Austria
11Ordensklinikum, Linz Elisabethinen, Austria
12Department of Internal Medicine 2, Wiener Gesundheitsverbund, Klinik Donaustadt, Vienna, AUT
13LKH Hochsteiermark, Department of Internal Medicine, Hematology and Internal Oncology, Leoben, AUT
14Department of Internal Medicine 2, Landeskrankenhaus Feldkirch, Feldkirch, AUT
15Internal Medicine I: Medical Oncology and Hematology, Ordensklinikum Linz GmbH, Barmherzige Schwestern, Linz, AUT
16Kepler Universitätsklinik Linz, Linz, Austria
17Experimental and Clinical Research Center (ECRC), Max Delbrück Center for Molecular Medicine and Charité-Universitätsmedizin, Berlin, Germany
18University Hospital Krems, Department of Internal Medicine 2, Karl Landsteiner Private University of Health Sciences, Krems, Austria
19Clinical Department for Internal Medicine, University Hospital St Poelten, Karl Landsteiner University of Health Sciences, St. Poelten, Austria
20Department of Internal Medicine I, KH Barmherzige Brüder Graz, Graz, Austria
213rd Medical Dept. with Haematology, Medical Oncology, Haemostaseology, Rheumatology and Infectiology, Oncologic Center, Paracelsus Medical University, Salzburg, Salzburg, Austria

Andrew Palmer, BS1, Garth Rauscher2*, Alexa Schoen3*, Madelyn Burkart, M.D.4, Ashley Dunton5*, Cherry Au6*, Ami Dave7*, Ahmad Nassar, MBBS8, Shaoshi Zhu9*, Amani Erra10*, Vinod Solipuram, MD11*, Ivy Abraham12*, Stephanie B. Tsai13, Maryam Zia, MD14, Melissa L. Larson15, Damiano Rondelli, MD16*, Jessica K. Altman, MD17, Wendy Stock, MD18, Irum Khan, MD19, Olatoyosi Odenike, MD18 and Anand Ashwin Patel, MD18

1University of Chicago Pritzker School of Medicine, Chicago, IL
2University of Illinois At Chicago School of Public Health, Chicago, IL
3Department of Medicine, Northwestern University, Chicago, IL
4Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
5Rush University, Chicago, IL
6Rush University, Chicago
7Division of Hematology, Oncology and Stem Cell Transplant, Rush University, Chicago
8University of Illinois Chicago, Chicago, IL
9University of Illinois College of Medicine, Chicago
10Division of Hematology and Oncology, John H. Stroger Jr. Hospital of Cook County, Chicago, IL
11John H. Stroger Jr. Hospital of Cook County, Chicago
12UChicago Medicine, Flossmoor, IL
13Loyola University Medical Center, Chicago, IL
14Division of Hematology and Oncology, John H. Stroger Hospital of Cook County, Chicago, IL
15Division of Hematology, Oncology and Stem Cell Transplant, Rush University Medical Center, Chicago, IL
16Division of Hematology/Oncology, University of Illinois College of Medicine, Chicago, IL
17Department of Medicine, Division of Hematology/Oncology and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Northwestern University Feinberg School of Medicine, Chicago, IL
18Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL
19Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL

Amer M. Zeidan, MD1, Yanqing Xu2*, Tatyana A. Kapustyan2*, Kaylee Miu2*, Cheng Chen, PhD3*, Rajesh Kamalakar2*, Chia-Wei Lin4*, Esprit Ma4*, Melissa Montez4*, Zheng Wu5*, Tracy Yee5*, Haiyan Sun5*, Andrew Rava5*, Sonia Kim5* and Scott F Huntington1

1Yale School of Medicine, Smilow Cancer Hospital at Yale New Haven, New Haven, CT
2AbbVie, Inc., Health Economics and Outcomes Research – Oncology, Chicago, IL
3AbbVie, Inc, North Chicago, IL
4Genentech, Inc., South San Francisco, CA
5Genesis Research Group, Hoboken, NJ

Ella Johnson, BA1*, Karan Bansal, MPH2*, Chen Dai, MS1*, Wajiha Mekki2*, Sindhu Dwarampudi, BS2*, Lindsey Hageman, MPH2*, Joshua Knapp, BS3*, Pankit Vachhani, MD4*, Ravi Bhatia, MD4, Yohei Hisada, PhD5*, Neil Zakai6, Smita Bhatia, MD, MPH2 and Radhika Gangaraju, MD7,8

1Institute for Cancer Outcomes and Survivorship, University of Alabama At Birmingham, Birmingham, AL
2Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL
3Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham
4Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL
5Division of Hematology and Oncology, University of North Carolina, Chapel Hill, NC
6Division of Hematology and Oncology, University of Vermont, Burlington, VT
7Institute for Cancer Outcomes and Survivorship, University Of Alabama, Birmingham, AL
8Division of Hematology and Oncology, University Of Alabama at Birmingham, Birmingham, AL

Zaid Abdel Rahman, MD1,2, Abeer Yaseen, MD3*, Albatol Alamoush4*, Lamya Abu Shanab4*, Teeba Mubaydeen4*, Rnad Khader4*, Ahmad Alyamani4*, Rand Al-Hadaddin4*, Sulaiman Sayaydeh4*, Omar Ahmad Shahin, MD5*, Waleed Kamel Da'Na, MD4*, Lina Marei, MD4*, Kamal Alrabi, MD4*, Yazan Talab, MD4* and Mohammad Makoseh4*

1Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan
2University of Jordan, Amman, Jordan
3KIng Hussein Cancer Center, Amman, Jordan
4King Hussein Cancer Center, Amman, Jordan
5king Hussein cancer center internal medicine department, Amman, Jordan

Shireen J. Usman, MD1, Jozal Moore, MD1, Jane L. Liesveld, MD1, Laura M. Calvi, M.D.1 and Jason H. Mendler, MD, PhD2

1Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY
2University of Rochester Medical Center, Rochester, NY

Nisha Thiagarajah, MBBS, FRACP, FRCPA1, Mark R Dowling, MBBS, PhD1, Karin Dunne2*, Donna Aarons3*, Jenny Collins4*, Steven Tran5*, Shaun Fleming, MBBS, FRACP, FRACPA6*, Gaurav Sutrave, MBBS, BSc, FRACP, FRCPA7*, Devendra Hiwase, MD, MBBS, PhD, FRACP, FRCPA8, Chun Yew Fong, MBBS, FRACP, FRCPA, PhD9*, Blake Hsu10*, Duncan Purtill, MBBS, FRACP, FRCPA11*, Anne-Marie Watson, FRACP, FRCPA12*, Glen A Kennedy13*, William S Stevenson, MBBS, FRACP, FRCPA, PhD14*, Stephen Robert Larsen, MBBS PhD FRACP FRCPA15, John Moore, MBBS MD FRACP FRCPA16, Travis Perera, MBChB17*, David S. Ritchie, MBChB PhD1,18, Andrew Wei, MBBS, PhD1,18*, Andrew W. Roberts, MBBS, PhD1,18, Nada Hamad, MBBS, MSc, BSc16,19,20 and Ashish Bajel, MBBS, FRACP, FRCPA1,18

1Peter MacCallum Cancer Centre and the Royal Melbourne Hospital, Melbourne, VIC, Australia
2Australasian Leukaemia & Lymphoma Group, Melbourne, VIC, Australia
3Australia and New Zealand Transplant and Cellular Therapy Registry, Sydney, NSW, Australia
4Australasian Leukaemia and Lymphoma Group, Melbourne, VIC, Australia
5Australia and New Zealand Transplant and Cellular Therapies Registry, Darlinghurst, NSW, Australia
6Department of Malignant Haematology & Stem Cell Transplantation, The Alfred Hospital, Melbourne, VIC, Australia
7Westmead Institute For Medical Research, Westmead, AUS
8Royal Adelaide Hospital, Adelaide, SA, Australia
9Department of Hematology, Austin Health, Heidelberg, VIC, Australia
10Department of Haematology, Christchurch Hospital, Christchurch, New Zealand
11Haematology Department, Fiona Stanley Hospital, Murdoch, Western Australia, Australia
12Haematology, Liverpool Hospital, Sydney, Australia
13Haematology and Bone Marrow Transplant, Royal Brisbane and Women's Hospital, Herston, QLD, Australia
14Royal North Shore Hospital, Sydney, AUS
15Royal Prince Alfred Hospital, Camperdown, Australia
16Haematology Department, The Kinghorn Cancer Centre, St Vincent's Hospital, Darlinghurst, NSW, Australia
17Wellington Blood and Cancer Centre, Wellington Hospital, Wellington South, New Zealand
18Department of Medicine, University of Melbourne, Melbourne, VIC, Australia
19School of Clinical Medicine, Faculty of Medicine and Health, The University of New South Wales, Sydney, NSW, Australia
20School of Medicine, University of Notre Dame, Sydney, Australia

Elena Crisa, MD1*, Daniela Cilloni, MD2*, Marta Riva3*, Enrico Balleari, MD4*, Daniela Barraco, MD5*, Lorenza Borin, MD6*, Michela Calmasini7*, Anna Calvisi, MD8*, Isabella Capodanno, MD9*, Matteo Giovanni Della Porta, MD10*, Elisa Diral, MD11*, Bruno Fattizzo, MD12, Susanna Fenu, MD13*, Stefania Paolini, MD, PhD14*, Carlo Finelli, MD14*, Claudio Fozza, MD15*, Chiara Frairia, MD16*, Valentina Giai, MD, PhD17*, Mauro Turrini, MD18*, Maria Antonia Isoni, MD19*, Federico Itri, MD20*, Luca Maurillo, MD21*, Alfredo Molteni, MD22*, Giuseppe Alberto Palumbo, MD23*, Anna Maria Pelizzari, MD24*, Federica Pilo, MD25*, Antonella Poloni, PhD26*, Costanza Bosi, MD27*, Grazia Sanpaolo, MD28*, Rosaria Sancetta, MD29*, Cristina Amato, SN30*, Valeria Santini, MD30, Maria Teresa Voso, MD31, Sam Salek32*, Tatyana Ionova33*, Annamaria Nosari, MD34* and Esther Natalie Oliva, MD35

1Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy
2Department of Clinical and Biological Sciences, University of Turin, Orbassano, Italy
3Department of Hematology and Oncology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
4IRCCS Policlinico Ospedale San Martino, Genova, Italy
5Dipartimento di Ematologia - ASST Sette Laghi, Ospedale di Circolo e Fondazione Macchi, Varese, Italy
6Hematology, Irccs San Gerardo di Monza, Monza, ITA
7Associazione Italiana Pazienti Sindromi Mielodisplastica AIPASIM, milano, Italy
8SC Ematologia,CTMO e Laboratorio specialistico, Ospedale S Francesco, Nuoro, Italy
9Hematology Unit, Azienda Unità Sanitaria Locale-IRCCS, Reggio Emilia, Italy
10IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy
11Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute, Milan, Italy
12Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy
13Hematology and Stem Cell Transplant, St. Giovanni Addolorata Hospital, Rome, Italy
14IRCCS Azienda Ospedaliero-Universitaria di Bologna – Institute of Hematology “Seràgnoli", Bologna, Italy
15Hematology Unit – Azienda Ospedaliera Universitaria of Sassari, University of Sassari, Sassari, Italy
16Hematology, AOU Città della Salute e della Scienza di Torino, Torino, Italy
17Hematology, AOU Città della Salute e della Scienza di Torino, Turin, Italy
18Hematology Unit, Division of Hematology, Valduce Hospital, Como, Como, Italy
19Istituto di Ematologia, Università di Sassari, Sassari, Italy, sassari, Italy
20Dipartimento di Scienze Cliniche e Biologiche, AOU San Luigi Gonzaga, Orbassano, Italy
21Department of Onco-Hematology, Fondazione Policlinico Tor Vergata, Rome, Italy
22Ospedale Niguarda Ca' Granda, Milano, ITA
23Department of Scienze Mediche, Chirurgiche e Tecnologie Avanzate “G.F. Ingrassia”, University of Catania, Catania, Italy
24ASST Spedali Civili Di, Brescia, Italy
25Hematology and BMT Unit, A.Businco hospital, Cagliari, Italy
26Hematology Unit, Department of Clinical and Molecular Sciences, Università Politecnica delle Marche, Ancona, Ancona, Italy
27Ematologia e Centro Trapianti, Ospedale Guglielmo di saliceto, Piacenza, Italy
28Hematology Unit, IRCCS Casa Sollievo Della Sofferenza, San Giovanni Rotondo, Italy
29Hematology Unit, Dell'Angelo Hospital, Venezia-Mestre, Italy
30MDS Unit, Hematology, DMSC, AOU Careggi, University of Florence, Florence, Italy
31Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
32School of Life and Medical Sciences, University of Hertfordshire, Hatfield, United Kingdom
33St. Petersburg State University Hospital, Saint-Petersburg, Russian Federation
34Associazione Italiana Pazienti Sindromi Mielodisplastica AIPASIM, Milano, ITA
35Hematology Unit, Grande Ospedale Metropolitano BMM, Reggio Calabria, Reggio Calabria, Italy

Jesus D Gonzalez-Lugo, MD1, Yazan F Madanat, MD2, Nidia Zapata, MD3, Deedra Nicolet, MS4*, Victoria Klein, MS4*, Charles Foucar, MD5, Krzysztof Mrózek, MD, PhD4, Nicole Twardowski, DO1, Sharlene Dong, MD6, Haitham Abdelhakim, MD1, Ana Varela Constantino, MD7*, Judith Cruz Velazquez3*, Diana Arcos3*, Angelica Santiago Medina3*, Jose Ramiro Espinoza Zamora, MD3*, Alice Mims, MD4, Tara L. Lin, MD1, Ann-Kathrin Eisfeld, MD8, Onyee Chan, MD9* and Andres Gomez-De Leon, MD10

1Division of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas Cancer Center, Westwood, KS
2Division of Hematology/Oncology, Department of Internal Medicine, University of Texas Southwestern, Dallas, TX
3Instituto Nacional de Cancerologia, Mexico City, Mexico
4The Ohio State University Comprehensive Cancer Center, Columbus, OH
5University of New Mexico, Ann Arbor, MI
6University of Texas Southwestern Medical Center, Dallas, TX
7Tec Salud, Instituto Tecnologico de Estudios Superiores de Monterrey, Monterrey, Mexico
8The Ohio State University, Columbus, OH
9H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
10Universidad Autonoma de Nuevo Leon. Facultad de Medicina y Hospital Universitario "Dr. Jose Eleuterio Gonzalez", Monterrey, Nuevo Leon, Mexico

John X Wei, MD1, Mendel Goldfinger2*, Marina Konopleva3, Ioannis Mantzaris, MD2, Amit Verma, MD4 and Eric J. Feldman, MD5*

1Department of Oncology, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY
2Montefiore Einstein Comprehensive Cancer Center, Blood Cancer Institute, Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY
3Department of Oncology, Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, Bronx, NY
4Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY
5Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY

Cassandra Duarte, MD1, Diana Abbott, PhD2, Christine M. McMahon, MD3, Andrew Kent, MD, PhD4, Marc Schwartz, MD5, Jonathan Gutman, MD4, Daniel A Pollyea, MD5 and Maria L Amaya, MD, PhD6

1University of Colorado Cancer Center, Denver, CO
2Center for Innovative Design and Analysis (CIDA), Department of Biostatistics and Informatics, Colorado School of Public Health, University of Colorado, Anschutz Medical Campus, Aurora, CO
3Anschutz Medical Campus, Division of Hematology, University of Colorado School of Medicine, Aurora, CO
4Division of Hematology, University of Colorado, Aurora, CO
5Division of Hematology, University of Colorado, Denver, CO
6University of Colorado, Aurora, CO

Andrew T. Kuykendall, MD1, Francesca Palandri, MD, PhD2*, Shiyuan Zhang, MSc3*, Tom Liu, MS3*, Mirko Fillbrunn, PhD4*, Adina Zhang4*, Gautam Sajeev, D.Sc4*, James Signorovitch, PhD4*, Dwaipayan Patnaik, MD, MBBS5 and Aaron T. Gerds, MD, MS6

1Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
2IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico S. Orsola-Malpighi, Istituto di Ematologia "Seràgnoli", Bologna, Italy
3GSK plc, Collegeville, PA
4Analysis Group, Inc., Boston, MA
5GSK plc, Baar, Switzerland
6Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH

Ian Thomas1*, Joanna Canham2*, Sean Johnson3*, Nuria Marquez4*, Sophie King1*, Jane Leahy5*, Mike Dennis, MD, MRCP, FRCPath6, Nigel H. Russell, MD7, Abin Thomas1* and Steven Knapper, DM8

1Centre for Trials Research, Cardiff University, Cardiff, United Kingdom
2Cardiff University, Cardiff, WAL, GBR
3Cardiff University, Cardiff, United Kingdom
4Cardiff University, Cardiff, GBR
5Private affiliation, PPI Representative, London, United Kingdom
6The Christie NHS Foundation Trust, Manchester, United Kingdom
7Nottingham University Hospital (City Hospital Campus), Nottingham, ENG, United Kingdom
8Univ. Hosp. of Wales, Cardiff, GBR

Ashley C. Woods, MD1*, Dianne D. Pulte, MD1, Kamar Godder, MD1*, Emily Jen, MD, PhD1*, Nina Kim2*, Robert Le, MD1*, Catherine C. Lerro, MPH, PhD3*, Donna Rivera, MS, PharmD4*, Gulsum Pamuk, MD1*, Nicole J. Gormley, MD1*, Marc R. Theoret, MD5*, Kelly J. Norsworthy, MD2* and R. Angelo De Claro, MD2*

1US Food and Drug Administration, Silver Spring, MD
2U.S. Food and Drug Administration, Silver Spring, MD
3Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, MD
4Oncology Center or Excellence, US Food and Drug Administration, Silver Spring, MD
5Center for Drug Evaluation and Research, Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, MD

John O. Mascarenhas, MD1, Aaron R. Perkins2*, Yu-Hsuan Shih3*, Derek Tang3*, Sara Vergara3* and Carlos A. Alvarez2*

1Icahn School of Medicine at Mount Sinai, New York, NY
2Texas Tech University Health Sciences Center and Center for Excellence in Real-World Evidence, Dallas, TX
3Bristol Myers Squibb, Princeton, NJ

Manuel Espinoza-Gutarra, MD1, Brooke Jarrett, PhD2*, Xiaoliang (Wendy) Wang, PhD3, Anosheh Afghahi, MD2,4* and Sejong Bae, PhD5*

1O'Neal Comprehensive Cancer Center at University of Alabama at Birmingham, Birmingham, AL
2Flatiron Health, New York, NY
3Flatiron Health, INC., New York, NY
4University of Colorado School of Medicine, Aurora, CO
5O'Neal Comprehensive Cancer Center at UAB, Birmingham, AL

Rahul Mishra, MBBS1, Noha Sharafeldin, PhD, MSc2, Ruchi Desai, MD3*, Pankit Vachhani, MD4* and Tania Jain, MD5

1Department of Internal Medicine, Anne Arundel Medical Center, Annapolis, MD
2Division of Hematology and Oncology, Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL
3Department of Medicine, Division of Hematology, Oncology, and Palliative Care, Virginia Commonwealth University, Richmond, VA
4Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL
5Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD

Maria Agustina Perusini, Eleanore Louise Musick*, Filza Gul*, May Chiu*, Mohammad Alwadi*, Noora Obaidallah*, Jaeyoon John Kim*, Danielle Pyne*, Jose-Mario Capo-Chichi, PhD* and Dennis Dong Hwan Kim, MD, PhD

Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada

Chi-Joan How, MD1, Bridget Coffey2*, Christina M. Dieli-Conwright3*, Gabriela S. Hobbs, MD4, Hermioni L Amonoo, MD5, Areej El-Jawahri, MD6 and Richard Newcomb, MD7*

1Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Boston, MA
2Massachusetts General Hospital, Boston
3Dana Farber Cancer Institute, Boston
4Division of Hematology/Oncology, Massachusetts General Hospital, Boston, MA
5Harvard Medical School, Boston, MA
6Massachusetts General Hospital, Allston, MA
7Massachusetts General Hospital, Winthrop, MA

Ehab L. Atallah, MD1, Islam Sadek, MD2*, David Wei, PhD2*, Dominick Latremouille-Viau, MSc3*, Carmine Rossi3*, Andrea Damon, PhD2*, Daisy Yang, PharmD, BCOP2*, Remi Bellefleur3*, Annie Guérin, MS4* and Kejal Jadhav, B.Pharm, MS2*

1Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
2Novartis Pharmaceuticals Corporation, East Hanover, NJ
3Analysis Group, Inc., Montreal, QC, Canada
4Analysis Group, Inc, Montreal, Canada

Naveen Pemmaraju, MD1, Jingbo Yu, MD, PhD2*, Anupama Vasudevan, BDS, MPH, PhD3*, Husain Qureshi, MBBS, MBA4*, Evan M. Braunstein, MD, PhD2* and Aleksander L. Chojecki, MD5

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Incyte Corporation, Wilmington, DE
3IntegraConnect PrecisionQ, West Palm Beach, FL
4Integra Connect Precision Q, West Palm Beach, FL
5Department of Hematologic Oncology and Blood Disorders, Atrium Health Levine Cancer Institute, Charlotte, NC

Michael Marrone, PhD1*, Lisa Morere2*, Abiola Oladapo, PhD, MSc, BPharm3*, Purvi Suthar, PharmD1*, Teena Sura2*, Anupama Vasudevan, BDS, MPH, PhD4*, Michael Vredenburg, PhD1*, Jia Zeng, PhD2*, Raajit Rampal, MD, PhD5 and John O. Mascarenhas, MD6

1Sobi Inc., Waltham, MA
2IntegraConnect, PrecisionQ, West Palm Beach, FL
3Sobi, Inc., Waltham, Massachusetts, USA, Waltham, MA
4IntegraConnect PrecisionQ, West Palm Beach, FL
5Memorial Sloan Kettering Cancer Center, New York, NY
6Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY

Thomas W. LeBlanc, MD, MA, MS1, Hannah Collacott2*, Valentín García Gutiérrez Sr.3, Ned Weinshenker4*, Ruth Fein Revell5*, Alicia O'Neill, MA6*, Anna P Cardellino6*, Shiyuan Zhang, MSc6*, Dwaipayan Patnaik, MD, MBBS7 and Melissa Ross2*

1Duke Cancer Institute, Hillsborough, NC
2Evidera, Bethesda, MD
3Hematology, Hospital Universitario Ramón y Cajal, Madrid, Spain
4Churchill Oaks Consulting and Myelofibrosis Patient Advocate, Salt Lake City, UT
5Health/Life Sciences Writer and Chronic Cancer Patient Advocate, Saratoga Springs, NY
6GSK plc, Collegeville, PA
7GSK plc, Baar, Switzerland

Elias Jabbour1*, Delphine Rea2, Mouna Bardey-Kanaan3*, Romuald Soichez3*, Nhan Thanh Nguyen3*, Deborah Kelly3*, Federica Rizzo3*, Petros Patos3* and Valentín García Gutiérrez Sr.4

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Hématologie, Hôpital Saint-Louis, Paris, France
3Incyte Biosciences International Sàrl, Morges, Switzerland
4Departamento de Hematología y Hemoterapia, Hospital Universitario Ramón y Cajal (IRYCIS), Madrid, Spain

Mahesh Swaminathan, MD1, Hussein A. Abbas, MD, PhD1, Guillermo Garcia-Manero, MD1, Naval Daver, MD2, Tapan M. Kadia, MD1, Courtney D. DiNardo, MD, MSc3, Gautam Borthakur, MD4, Elias Jabbour, MD5, Naveen Pemmaraju, MD1, Yesid Alvarado Valero, MD1, Maro Ohanian, DO1*, Nitin Jain, MD1, Nicholas J. Short, MD1, Prithviraj Bose, MD6, Koichi Takahashi, MD, PhD1, Hyunsoo Hwang, MS7*, Xuelin Huang, PhD7*, Paul Edelkamp Jr.8*, Sherry Pierce, BSN, BA1*, Uday Popat, MD9, Elizabeth J. Shpall, MD9, Richard E. Champlin, MD9, Hagop M. Kantarjian, MD1 and Farhad Ravandi, MBBS10

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2MD Anderson Cancer Center, Houston, TX
3Department of Leukemia, UT MD Anderson Cancer Center, Houston, TX
4Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
5Department of Leukemia, University of Texas M.D. Anderson Cancer Ctr., Houston, TX
6The University of Texas MD Anderson Cancer Center, Houston, TX
7Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
8Department of Enterprise Data Engineering & Analytics, The University of Texas MD Anderson Cancer Center, Houston, TX
9Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
10Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX

Philipp Berning1*, David Baden, MD2*, Philipp Faustmann, MD3*, Snjezana Janjetovic4*, Hanna Katharina Zieger5*, Jan Christian Schroeder3*, Giuliano Filippini Velazquez, MD6*, Anna Ossami Saidy4*, Hristo Boyadzhiev7,8*, Tim Sauer, MD9, Jan-Henrik Mikesch, MD1*, Niklas Gebauer10*, Susanne Ghandili, MD11*, Paul J. Bröckelmann, MD12*, Friederike Hildebrand13*, Veit L. Buecklein, MD13*, Rebecca Wurm-Kuczera, MD14*, Ulrich Keller14*, Georg Lenz1, Thomas Pabst7, Thomas Melchardt, MD15*, Claudia Lengerke, MD3, Maher Hanoun, MD, PhD5*, Evgenii Shumilov1* and Ulrike Bacher16*

1Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany
2Department of Internal Medicine II (Hematology/Oncology), University Hospital Schleswig-Holstein Campus Kiel, Kiel, Germany
3Department for Internal Medicine II, Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, Tuebingen, Germany
4Department of Hematology and Cell Therapy, Helios Klinikum Berlin-Buch, Berlin, Germany
5Department of Hematology and Stem Cell Transplantation, University Hospital Essen, Essen, Germany
6Department of Hematology, University Hospital Augsburg, Augsburg, Germany
7Department of Medical Oncology, Inselspital, University Hospital Bern, University of Bern, Bern, Switzerland
8Habichtswald Hospital, Kassel, Germany
9Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany
10Department for Hematology and Oncology, University Hospital Schleswig-Holstein, Campus Luebeck, Luebeck, Germany
11Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
12University of Cologne, Faculty of Medicine and University Hospital of Cologne, Department I of Internal Medicine, and Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), and German Hodgkin Study Group (GHSG), Cologne, Germany
13Department of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany
14Hematology, Oncology and Cancer Immunology, Charité - University Medical Center Berlin, Campus Benjamin Franklin, Berlin, Germany
15Paracelsus Medical University, Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Salzburg, Austria
16Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland

*signifies non-member of ASH